AstraZeneca says restructuring won't lead to net reduction in jobs
AZN•AstraZeneca said its restructuring will not lead to a net reduction in jobs, with job losses not concentrated in one area and employees also reskilled and upskilled. Its CEO said the company has made good progress on drug pricing in Japan, while discussions continue in Europe.
1. Jobs and drug pricing
AstraZeneca's CFO said the restructuring will not lead to a net reduction in jobs, and that job losses will not be in one specific area. The company will also reskill and upskill employees. Its CEO said AstraZeneca has made good progress on global drug pricing in Japan, while discussions are ongoing in Europe.
